Diabetic heart and the cardiovascular surgeon

Cardiovascular and Hematological Disorders - Drug Targets

Volumn 8, Issue 2, 2008, Pages 147-152

  Yosefy, Chaim ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Diabetes mellitus; Heart surgeon; Risk factors

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTERY INTIMA PROLIFERATION; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARDIOVASCULAR SURGERY; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DOCTOR PATIENT RELATION; HUMAN; HYPERGLYCEMIA; LEG AMPUTATION; LIMB SALVAGE; MEDICAL PRACTICE; MORTALITY; NONHUMAN; PERIPHERAL VASCULAR DISEASE; POSTOPERATIVE COMPLICATION; REVIEW; RISK FACTOR; SURGEON; TEAMWORK; FEMALE; MALE; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PATIENT CARE;

CARDIOVASCULAR DISEASES; CARDIOVASCULAR SURGICAL PROCEDURES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERGLYCEMIA; MALE; PATIENT CARE TEAM; PHYSICIAN-PATIENT RELATIONS; RISK FACTORS;

EID: 48249124595     PISSN: 1871529X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152908784533694     Document Type: Review

References (58)

1. Kuusisto, J.; Mykkanen, L.; Pyorala, K.; Laakso, M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes, 1994, 4, 960-967.
2. The Diabetes Control and Complications Trial (DCCT) Research Group. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int., 1995, 47, 1703-1720.
3. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ, 1998, 317, 703-713.
4. Hu, F.B.; Stampfer, M.J.; Solomon, C.G.; Liu, S.; Willett, W.C.; Speizer, F.E.; Nathan, D.M.; Manson J.E. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch. Intern. Med., 2001, 161, 1717-1723.
5. Haffner, S.M.; Lehto, S.; Ronnemaa, T.; Pyorala, K.; Laakso, M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med., 1998, 339, 229-234.
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 2001, 285, 2486-2497.
7. Feskens E.J.; Kromhout D. Glucose tolerance and the risk of cardiovascular disease: the Zutphen Study. J. Clin. Epidemiol., 1992, 45, 1327-1334.
8. Kjaergaard, S.C.; Hansen, H.H.; Fog, L.; Bulow, I.; Christensen, P.D. In-hospital outcome for diabetic patients with acute myocardial infarction in the thrombolytic era. Scand. Cardiovasc. J., 1999, 33, 166-170.
9. Newman, A.B.; Siscovick, D.S.; Manolio, T.A.; Polak, J.; Fried, L.P.; Borhani, N.O.; Wolfson, S.K. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation, 1993, 88, 837-845.
10. Jude, E.B.; Oyibo, S.O.; Chalmers, N.; Boulton, A.J. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care, 2001, 24, 1433-1437.
11. Temelkova-Kurktschiev, T.S.; Koehler, C.; Henkel, E.; Leonhardt, W.; Fuecker, K.; Hanefeld, M. Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care, 2000, 23, 1830-1834.
12. Fabris, F.; Zanocchi, M.; Bo, M.; Fonte, G.; Poli, L.; Bergoglio, I.; Ferrario, E.; Pernigotti, L. Carotid plaque, aging, and risk factors. A study of 457 subjects. Stroke, 1994, 25, 1133-1140.
13. Folsom, A.R.; Rasmussen, M.L.; Chambless, L.E.; Howard, G.; Cooper, L.S.; Schmidt, M.I.; Heiss, G. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Diabetes Care, 1999, 22, 1077-1083.
14. Muggeo, M.; Bolli, G.; Bompiani, G.; Brunetti, P.; Capani, F.; Cavallo-Perin, P.; Comaschi, M.; Cordera, R.; Crepaldi, G.; Cucinotta, D.; Di Mario, U.; Fedele, D.; Ferrannini, E.; Giorgino, R.; Giugliano, D.; Gnudi, A.; Mancini, M.; Menzinger, G.; Pagano, G.; Pontiroli, A.E.; Pozza, G.; Santeusanio, F.; Tiengo, B.A.; Trovati, M.; Vigneri, R. Glycemic control and cardiovascular disease in Type 2 diabetes mellitus. Beyond fasting glycemia and glycosylated hemoglobin. Diabetes Nutr. Metab., 2000, 13, 182-185.
15. Williams, S.B.; Cuaco, J.A.; Roddy, M.A.; Johnstone, M.T.; Creager, M.A. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J. Am. Coll. Cardiol., 1996, 27, 567-574.
16. De Vriese, A.S.; Verbeuren, T.J.; Van de Voorde, J.; Lameire, N.H.; Vanhoutte, P.M. Endothelial dysfunction in diabetes. Br. J. Pharmacol., 2000, 130, 963-974.
17. Hussain, M.J.; Peakman, M.; Gallati, H.; Lo, S.S.; Hawa, M.; Viberti, G.C.; Watkins, P.J.; Leslie, R.D.; Vergani, D. Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia, 1996, 39, 60-69.
18. Uemura, S.; Matsushita, H.; Li, W.; Glassford, A.J.; Asagami, T.; Lee, K.H.; Harrison, D.G.; Tsao, P.S. Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ. Res., 2001, 88, 1291-1298.
19. Li, Y.; Woo, V.; Bose, R. Platelet hyperactivity and abnormal Ca(2+) homeostasis in diabetes mellitus. Am. J. Physiol. Heart Circ. Physiol., 2001, 280, H1480-H1489.
20. Vinik, A.I.; Erbas, T.; Park, T.S.; Nolan, R; Pittenger, G.L. Platelet dysfunction in type 2 diabetes. Diabetes Care, 2001, 24, 1476-1485.
21. Kunjathoor, V.V.; Wilson, D.L.; LeBoeuf, R.C. Increased atherosclerosis in streptozotocin-induced diabetic mice. J. Clin. Invest., 1996, 97, 1767-1773.
22. Colwell, J.A.; Helushka, P.V.; Sarji, K.E.; Lopes-Virella, M.F.; Sagel, J. Vascular disease in diabetes: pathophysiological mechanisms and therapy. Arch. Inern. Med., 1979, 139, 225-230.
23. Williamson, J.R.; Kilo, C. Vascular complications in diabetes mellitus. N. Engl. J. Med., 1980, 302, 399-400.
24. Fuller, J.H.; Keen, H.; Jarret R.J.; Omer, T.; Meade, T.W.; Chakrabarti, R.; North, W.R.; Stirling Y. Haemostatic variables associated with diabetes and its complications. Br. Med. J., 1979, 2, 964-966.
25. Shin, B.; Joseph, S.I: hyperglycemic hyperosmolar nonketotic coma following Diazoxide, anesthesia and operation. Anests Analg., 1977, 56, 506-508.
26. Shuman, C.R: Surgery and diabetes, in Ellenberg M, Rifkin H (eds): diabetes mellitus. Theory and Practice, 3rd ed. Medical Examination Publishing Co. New York. 1993, 679-687.
27. Vigorito, C.; Botocchi, S.; Bonzani, G.; Giudice, P.; Miceli, D.; Piscione, F.; Condorelli, M. Severity of coronary artery disease is patients with diabetes mellitus. Angiorgraphic study of 34 diabetic and 120 non-diabetic patients. Am. Heart J., 1980, 100, 782-787.
28. Fallow, G.D.; Singh, J. The prevalence, type and severity of cardiovascular disease in diabetic and non-diabetic patients: a matched- paired retrospective analysis using coronary angiography as the diagnostic tool. Mol. Cell Biochem., 2004, 261, 263-269.
29. Flaherty, J.D.; Davidson, C.J. Diabetes and coronary revascularization. JAMA, 2005, 293, 1501-1508.
30. Morris, J.J.; Smith, L.R.; Jones, R.H.; Glower, D.D.; Morris, P.B.; Muhlbaier, L.H.; Reves, J.G.; Rankin, J.S. Influence of diabetes and mammary artery grafting on survival after coronary bypass. Circulation, 1991, 84(5 suppl.):III, 275-284.
31. Thourani, V.H.; Weintraub, W.S.; Stein, B.; Gebhart, S.S.; Craver, J.M.; Jones, E.L.; Guyton, R.A. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann. Thorac. Surg., 1999, 67, 1045-1052.
32. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J. Am. Coll. Cardiol., 2000, 35, 1122-1129.
33. Abizaid, A.; Costa, M.A.; Centemero, M.; Abizaid, A.S.; Legrand, V.M.; Limet, R.V.; Schuler, G.; Mohr, F.W.; Lindeboom, W.; Sousa, A.G.; Sousa, J.E.; van Hout, B.; Hugenholtz, P.G.; Unger F.; Serruys, P.W. Arterial Revascularization Therapy Study Group. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation, 2001, 104, 533-538.
34. Legrand, V.M.; Serruys, P.W.; Unger, F.; van Hout, B.A.; Vrolix M.C.; Fransen, G.M.; Nielsen, T.T.; Paulsen, P.K.; Gomes, R.S.; de Queiroz e Melo, J.M.; Neves, J.P.; Lindeboom, W. Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease. Circulation, 2004, 109, 1114-1120.
35. Ferguson, T.B. Jr.; Hammill, B.J.; Peterson, E.D.; DeLong, E.R.; Grover, F.L; STS National Database Committee. A decade of Change-risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons. Am. Thorac. Surg., 2002, 73, 480-489.
36. Rajakaruna, C.; Rogers, C.A.; Suranimala, C.; Angelini, G.D.; Ascione, R. The effect of diabetes mellitus on patients undergoing coronary surgery: a risk- adjusted analysis. J. Thorac. Cardiovasc. Surg., 2006, 132, 802-810.
37. Malmberg, K.; Yusuf, S.; Gerstein, H.C.; Brown, J.; Zhao, F.; Hunt, D.; Piegas, L.; Calvin, J.; Keltai, M.; Budaj, A. Impact of diabetes on long term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation, 2000, 102, 1014-1019.
38. McGuire, D.K.; Emanuelsson, H.; Granger, C.B.; Magnus Ohman E.; Moliterno, D.J.; White, H.D.; Ardissino, D.; Box, J.W.; Califf, R.M.; Topol, E.J. Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Finding from the GUSTO-IIb, study. GUSTO IIb Investigators. Eur. Heart J., 2000, 21, 1750-1758.
39. king, H.; Aubert, R.E.; Herman, W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care, 1998, 21, 1414-1431.
40. Bertrand, M.E.; Simoons, M.L.; Fox, K.A.; Wallentin, L.C.; Hamm, C.W.; McFadden, E.; De Feyter, P.J.; Specchia, G.; Ruzyllo W. Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur. Heart J., 2002, 23, 1809-1840.
41. Cameron, A.; Davis, K.B.; Green, G.E.; Myers, W.O.; Pettinger, M. Clinical implications of internal mammary artery bypass grafts: the Coronary Artery Surgery Study experience. Circulation, 1988, 77, 815-819.
42. Loop, F.D.; Lytle, B.W.; Cosgrove, D.M.; Stewart, R.W.; Goormastic, M.; Williams, G.W.; Golding, L.A.; Gill, C.C.; Taylor, P.C.; Sheldon, W.C. Influence of the internal-mammary artery graft on 10-year survival and other cardiac events. N. Engl. J. Med., 1986, 314, 1-6.
43. Cosgrove, D.M.; Loop, F.D.; Lytle, B.W.; Gill, C.C.; Golding, L.A.; Gibson, C.; Stewart, R.W.; Taylor, P.C.; Goormastic, M. Predictors of reoperation after myocardial revascularization. J. Thorac. Cardiovasc. Surg., 1986, 92, 811-821.
44. Loop, F.D.; Lytle, B.W.; Cosgrove, D.M.; Mahfood, S.; McHenry, M.C.; Goormastic, M.; Stewart, R.W.; Golding, L.A.; Taylor, P.C. J. Maxwell Chamberlain memorial paper. Sternal wound complications after isolated coronary artery bypass grafting: Early and late mortality, morbidity and cost of care. Ann. Thorac. Surg., 1990, 49, 179-186.
45. Redberg R.F.; Greenland, P.; Fuster, V.; Pyorala, K.; Blair, S.N.; Folsom, A.R.; Newman, A.B.; O'Leary D.H.; Orchard, T.J.; Psaty, B.; Schwartz, J.S.; Starke, R.; Wilson, P.W. Prevention Conference VI: Diabetes Cardiovascular disease: Writing Group III: risk assessment in persons with diabetes. Circulation, 2002, 105, e144-152.
46. Strategies for care of the type 2 diabetic patient excluding care of complications. Recommendations of ANAES (National Agency for Health Accreditation and Evaluation March 2000). Diabetes Metab., 2000, 26, 10-96.
47. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA, 1995, 273, 1421-1428.
48. Halliday, A.; Mansfield, A.; Marro, J.; Peto, C.; Peto, R.; Potter, J.; Thomas. D. MRC Asymtptomatic Carotid Surgery Trial (ACST) Collaborative Group. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet, 2004, 363, 1491-1502.
49. Axelrod, D.A.; Upchurch, G.R. Jr.; DeMonner, S.; Stanley, J.C.; Khuri, S.; Daley, J.; Henderson, W.G.; Hayward, R. perioperative cardiovascular risk stratification of patients with diabetes who undergo elective major vascular surgery. J. Vasc. Surg., 2002, 35, 894-901.
50. Treiman, G.S.; Treiman, R.L.; Foran, R.F.; Cossman, D.V.; Cohen, J.L.; Levin, P.M.; Wagner, W.H.; Davidson, M.B. The influence of diabetes mellitus on the risk of abdominal aortic surgery. Am. Surg., 1994, 60, 436-440.
51. Virkkunen, J.; Heikkihen, M.; Lepantalo, M.; Metsanoja, R.; Salenius, J.P. Finnvasc Study Group. Diabetes as an independent risk factor for early postoperative complications in critical limb ischemia. J. Vasc. Surg., 2004, 40, 761-767.
52. Pistolese, G.R.; Appolloni, A.; Ronchey, S.; Martelli, E. Carotid endarterectomyin diabetic patients. J. Vasc. Surg., 2001, 33, 148-154.
53. Ballotta, E.; Da Giau, G.; Renon, L. Is diabetes mellitus a risk factor for carotid endarterectomy? A prospective study. Surgery, 2001, 129, 146-152.
54. Rockman, C.B.; Saltzberg, S.S.; Maldonado, T.S.; Adelman, M.A.; Cayne, N.S.; Lamparello, P.J.; Riles, T.S. The safety of carotid endarterectomy in diabetic patients: clinical predictors of adverse outcome. J. Vasc. Surg., 2005, 42, 878-883.
55. Akbari, C.M.; Pomposelli, F.B. Jr, Gibbons, G.W, Campbell, D.R, Freeman, D.V, LoGerfo, F.W. Diabetes mellitus: a risk factor for carotid endarterectomy? J. Vasc. Surg., 1997, 25, 1070-1075.
56. Tseng, C.H.; Chong, C.K.; Tseng, C.P.; Cheng, J.C.; Wong, M.K.; Tai T,Y. Mortality, causes of death and associated risk factors in a cohort of diabetic patients after lower-extremity amputation: A 6.5-year follow-up study in Taiwan. Atherosclerosis, 2007.
57. Akbari, C.M.; Pomposelli, F.B. Jr, Gibbons, G.W, Campbell, D.R, Pulling, M.C, Mydlarz, D, LoGerfo, F.W. Lower extremity revascularization in diabetes: late observations. Arch. Surg., 2000, 135, 452-456.
58. Akbari, C.M.; Pulling, M.C.; Pomposelli, F.B. Jr.; Gibbons, G.W.; Campbell, D.R.; Logerfo, F.W. Gender and carotid endarterectomy: does it matter? J. Vasc. Surg., 2000, 31, 1103-1108.